OSiorain J, Cox S, Payet C, Nally F, He Y, Drewinksi T
FASEB J. 2024; 38(24):e70235.
PMID: 39686706
PMC: 11669068.
DOI: 10.1096/fj.202400508RR.
Hernandez-Espinosa D, Medina-Ruiz G, Scrabis M, Thathiah A, Aizenman E
J Neurochem. 2024; 169(2):e16239.
PMID: 39387604
PMC: 11810582.
DOI: 10.1111/jnc.16239.
Aksu M, van der Ent T, Zhang Z, Riza A, de Nooijer A, Ricano-Ponce I
J Infect. 2024; 89(6):106300.
PMID: 39357572
PMC: 11624491.
DOI: 10.1016/j.jinf.2024.106300.
Padin J, Perez-Ortiz J, Redondo-Calvo F
Int J Mol Sci. 2024; 25(14).
PMID: 39062796
PMC: 11277036.
DOI: 10.3390/ijms25147553.
Mytych J, Pan Z, Lopez-Davis C, Redinger N, Lawrence C, Ziegler J
Immunohorizons. 2024; 8(3):269-280.
PMID: 38517345
PMC: 10985058.
DOI: 10.4049/immunohorizons.2300109.
Circulating Soluble EPCR Levels Are Reduced in Patients with Ischemic Peripheral Artery Disease and Associated with Markers of Endothelial and Vascular Function.
Krug J, Bochenek M, Gogiraju R, Laubert-Reh D, Lackner K, Munzel T
Biomedicines. 2023; 11(9).
PMID: 37760900
PMC: 10526050.
DOI: 10.3390/biomedicines11092459.
Deletion of the non-adjacent genes and impairs human cytomegalovirus-mediated TNF receptor 2 surface upregulation.
Le-Trilling V, Maassen F, Katschinski B, Hengel H, Trilling M
Front Immunol. 2023; 14:1170300.
PMID: 37600801
PMC: 10437809.
DOI: 10.3389/fimmu.2023.1170300.
Alpha-1-antitrypsin antagonizes COVID-19: a review of the epidemiology, molecular mechanisms, and clinical evidence.
Bai X, Schountz T, Buckle A, Talbert J, Sandhaus R, Chan E
Biochem Soc Trans. 2023; 51(3):1361-1375.
PMID: 37294003
PMC: 10317171.
DOI: 10.1042/BST20230078.
ADAM10 and ADAM17, Major Regulators of Chronic Kidney Disease Induced Atherosclerosis?.
Maas S, Donners M, van der Vorst E
Int J Mol Sci. 2023; 24(8).
PMID: 37108478
PMC: 10139114.
DOI: 10.3390/ijms24087309.
Biomarkers of aging.
Bao H, Cao J, Chen M, Chen M, Chen W, Chen X
Sci China Life Sci. 2023; 66(5):893-1066.
PMID: 37076725
PMC: 10115486.
DOI: 10.1007/s11427-023-2305-0.
Identification of the regulatory mechanism of ACE2 in COVID-19-induced kidney damage with systems genetics approach.
Yang X, Lin C, Liu J, Zhang Y, Deng T, Wei M
J Mol Med (Berl). 2023; 101(4):449-460.
PMID: 36951969
PMC: 10034233.
DOI: 10.1007/s00109-023-02304-9.
Multiparametric Profiling of Neutrophil Function via a High-Throughput Flow Cytometry-Based Assay.
Timmer K, Floyd D, Scherer A, Crossen A, Atallah J, Viens A
Cells. 2023; 12(5).
PMID: 36899878
PMC: 10000770.
DOI: 10.3390/cells12050743.
The ADAM17 sheddase complex regulator iTAP/Frmd8 modulates inflammation and tumor growth.
Badenes M, Burbridge E, Oikonomidi I, Amin A, de Carvalho E, Kosack L
Life Sci Alliance. 2023; 6(4).
PMID: 36720499
PMC: 9889915.
DOI: 10.26508/lsa.202201644.
ADAM10-a "multitasker" in sepsis: focus on its posttranslational target.
Liao S, Lin Y, Liu L, Yang S, Lin Y, He J
Inflamm Res. 2022; 72(3):395-423.
PMID: 36565333
PMC: 9789377.
DOI: 10.1007/s00011-022-01673-0.
Elevation of circulating TNF receptor 2 in cancer: A systematic meta-analysis for its potential as a diagnostic cancer biomarker.
Kartikasari A, Cassar E, Razqan M, Szydzik C, Huertas C, Mitchell A
Front Immunol. 2022; 13:918254.
PMID: 36466914
PMC: 9708892.
DOI: 10.3389/fimmu.2022.918254.
Immunomodulatory role of metalloproteinase ADAM17 in tumor development.
Wang K, Xuan Z, Liu X, Zheng M, Yang C, Wang H
Front Immunol. 2022; 13:1059376.
PMID: 36466812
PMC: 9715963.
DOI: 10.3389/fimmu.2022.1059376.
Joint together: The etiology and pathogenesis of ankylosing spondylitis.
Xiong Y, Cai M, Xu Y, Dong P, Chen H, He W
Front Immunol. 2022; 13:996103.
PMID: 36325352
PMC: 9619093.
DOI: 10.3389/fimmu.2022.996103.
An ADAM17-Neutralizing Antibody Reduces Inflammation and Mortality While Increasing Viral Burden in a COVID-19 Mouse Model.
Hedges J, Snyder D, Robison A, Grifka-Walk H, Blackwell K, Shepardson K
Front Immunol. 2022; 13:918881.
PMID: 35757773
PMC: 9226444.
DOI: 10.3389/fimmu.2022.918881.
Tumor Necrosis Factor Receptor 2 (TNFR2): An Emerging Target in Cancer Therapy.
Medler J, Kucka K, Wajant H
Cancers (Basel). 2022; 14(11).
PMID: 35681583
PMC: 9179537.
DOI: 10.3390/cancers14112603.
ADAM Metalloproteinase Domain 17 Regulates Cholestasis-Associated Liver Injury and Sickness Behavior Development in Mice.
Almishri W, Swain L, DMello C, Le T, Urbanski S, Nguyen H
Front Immunol. 2022; 12:779119.
PMID: 35095853
PMC: 8793775.
DOI: 10.3389/fimmu.2021.779119.